Brainstorm Cell Therapeutics Inc.

(BCLI) Trade

By |

Profile

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

Contact Information

Website: www.brainstorm-cell.com
Email: pshah@brainstorm-cell.com
Main Phone: +1 201 488-0460
Address: 1325 Avenue of Americas
Address 2: 28th Floor
State: NY
City / Town: New York
Country: US
Postal Code: 10019

Issuer Information

Exchange: NSC
CEO: Chaim Lebovits
Employees: 44
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

Contact Information

Website: www.brainstorm-cell.com
Email: pshah@brainstorm-cell.com
Main Phone: +1 201 488-0460
Address: 1325 Avenue of Americas
Address 2: 28th Floor
State: NY
City / Town: New York
Country: US
Postal Code: 10019

Issuer Information

Exchange: NSC
CEO: Chaim Lebovits
Employees: 44
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 5.25 $ 0.26 (5.21%)
Last Price 5.25 Change $ 0.26 Change % 5.21 Tick N/A
Bid 5.15 Bid Size 100.00 Ask 5.22 Ask Size 100.00
Open 5.06 High 5.29 Low 4.85 Prev Close 4.99
Last Trade Volume 888,677 52 Wk Hi 17.96 52 Wk Low 3.64
Market Cap 165.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 31,567,592.00 EPS (TTM) -1.05 PE Ratio -4.80 Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 15
Number of Buys 1 15
Number of Sells 0 0
Net Activity 1249 130203
Last 10 Buys Shares
June Almenoff 1,000
Ralph Kern 1,000
Irit Arbel 1,000
Uri Yablonka 1,000
Yoram Bibring 1,000
Yoram Bibring 1,000
Anthony Fiorino 1,000
Anthony Fiorino 1,000
Last 10 Sell Shares
Robert G.L. Shorr 1,000
Malcolm S. Taub 1,000
Mordechai Friedman 1,000
Malcolm S. Taub 1,000
Robert G.L. Shorr 1,000
Malcolm S. Taub 1,000
Robert G.L. Shorr 1,000
Malcolm S. Taub 1,000
Robert G.L. Shorr 1,000
Robert G.L. Shorr 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 15 15 15 15
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 11.67 11.67 11.67 11.67
Standard Deviation 3.06 3.06 3.06 3.06
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 06/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1